Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
LA
Research Summary
AI-assisted · Grounded in filings
AKORN INC
Akorn Inc was a generic pharmaceutical manufacturer specializing in alternate dosage forms including ophthalmics, injectables, oral liquids, otics, and nasal sprays for both human and animal health markets. The Lake Forest, Illinois-based company, with CIK 3116, marketed branded and generic prescription drugs targeting healthcare providers and consumers seeking affordable medication options. Material risks included regulatory compliance challenges, as evidenced by a $7.9 million settlement with the DOJ for fraudulent billing practices, and manufacturing quality control issues that contributed to significant operational difficulties. The company faced mounting financial pressures and ultimately filed for Chapter 7 bankruptcy in February 2023 after unsuccessful restructuring efforts. View detailed SEC filings and financial reports for Akorn Inc on Earnings Feed.
Recent Filings
- 8-K132.0 KBAKORN INCOct 5, 5:19 PM ET·0000950137-05-012074
- 10-Q291.5 KBAKORN INCAug 8, 5:20 PM ET·0000950137-05-009815
- 8-K50.3 KBAKORN INCApr 19, 5:27 PM ET·0000950137-05-004609
- 8-K14.6 KBAKORN INCSep 30, 2:56 PM ET·0000950137-04-008186
- 8-K568.3 KBAKORN INCSep 27, 8:01 AM ET·0000950137-04-008027
- 8-K20.2 KBAKORN INCSep 22, 3:09 PM ET·0000950137-04-007902
- S-12.0 MBAKORN INCSep 21, 5:29 PM ET·0000950137-04-007889
- 8-K31.7 KBAKORN INCAug 31, 5:20 PM ET·0000950137-04-007400
- 8-K14.4 KBAKORN INCAug 31, 4:35 PM ET·0000950137-04-007397
- 10-Q306.1 KBAKORN INCAug 13, 5:14 PM ET·0000950137-04-006783
Insiders
6Tickers
No tickers on record
Addresses
business
1925 W. FIELD COURT, SUITE 300
LAKE FOREST, IL, 60045
mailing
1925 W. FIELD COURT, SUITE 300
LAKE FOREST, IL, 60045